High-dose bicalutamide after radiotherapy for locally advanced prostate cancer: a standard of care? [0.03%]
高剂量化疗联合放疗治疗局部晚期前列腺癌的标准化疗法？
Matthew D Galsky,William Kevin Kelly
Matthew D Galsky
Is botulinum A toxin an effective treatment for idiopathic detrusor overactivity and sensory urgency? [0.03%]
肉毒杆菌A毒素治疗原发性膀胱过度活动症及尿急的有效性分析
Arun Sahai,Prokar Dasgupta,Mohammad Shamim Khan
Arun Sahai
Does neurovascular bundle preservation at the time of radical prostatectomy improve urinary continence? [0.03%]
根治性前列腺切除术时保留神经血管束能改善尿控功能吗？
James A Eastham
James A Eastham
Ilia Zeltser,Jeffrey A Cadeddu
Ilia Zeltser
Treatment of muscle-invasive bladder cancer: is cystectomy enough? [0.03%]
肌 invasive膀胱癌的治疗：仅行膀胱切除术就够了吗？
Cheryl T Lee,James E Montie
Cheryl T Lee
Does the number of prostate biopsies performed affect the nature of the cancer identified? [0.03%]
前列腺活检的数量对其识别的癌症性质有影响吗？
Christopher R Porter
Christopher R Porter
Jorge M Arzola,Joshua S Hawley,Crystal Oakman et al.
Jorge M Arzola et al.
Background: A 67-year-old male, with a history of stable lower urinary tract symptoms, diabetes mellitus, benign prostatic hyperplasia, gonococcal urethritis, and excessive alcohol consumption, presented to the emergency ...
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer [0.03%]
疾病机制：遗传性平滑肌瘤病和肾细胞癌——一种独特的遗传性肾脏肿瘤形式
Sunil Sudarshan,Peter A Pinto,Len Neckers et al.
Sunil Sudarshan et al.
Renal cell carcinoma (RCC) represents a group of diseases linked by their primary site of origin, the kidney. Studies of families with a genetic predisposition to the development of kidney cancer have revealed that multiple genes are involv...
Yemi Akin-Olugbade,John P Mulhall
Yemi Akin-Olugbade
There are a wide variety of medical treatments that are available to the practicing urologist, including oral agents, topical creams and gels with or without iontophoresis, intralesional injection therapy, radiation therapy, extracorporeal ...
Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation [0.03%]
生物制剂作为前列腺癌的辅助治疗：与雄激素剥夺联合使用的理论依据
Eric C Nelson,Angelo J Cambio,Joy C Yang et al.
Eric C Nelson et al.
The prevalence of prostate cancer emphasizes the need for improved therapeutic options, particularly for metastatic disease. Current treatment includes medical or surgical castration, which initially induces apoptosis of prostate cancer cel...